Results 171 to 180 of about 113,669 (290)
Combinatorial classification model for predicting antipsychotic-induced hyperprolactinemia risk. [PDF]
Wang Z +5 more
europepmc +1 more source
Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data [PDF]
Tingjian Yan +5 more
openalex +1 more source
ABSTRACT Aims Characterising the association between childhood maltreatment (CM) and cognitive functioning in bipolar disorder (BD) is crucial for improving the understanding of how early environmental risk factors impact the presentation of the disorder.
Natalia E. Fares‐Otero +7 more
wiley +1 more source
Prescribing Patterns and Adverse Reactions of Antipsychotics in a North Indian Psychiatry Outpatient Department. [PDF]
Sodhi S +5 more
europepmc +1 more source
Antidepressant effect of atypical antipsychotic ziprasidone in albino rats
Rajiv Kumar +3 more
openalex +2 more sources
ABSTRACT Introduction Cognitive impairment in mood disorders and schizophrenia spectrum disorders hampers patients' clinical and functional outcomes. A key challenge in pro‐cognitive treatment development is the limited insight into the underlying neurocircuitry correlates of cognitive changes.
Viktoria Damgaard +10 more
wiley +1 more source
Weight gain under antipsychotic and mood stabilizing treatment: a narrative review about mechanisms and future options. [PDF]
Seiter HT +3 more
europepmc +1 more source
ABSTRACT Background and Hypothesis Deficits in processing speed (PS) and psychomotor speed (PMS) are core cognitive impairments in schizophrenia spectrum disorders, including first‐episode psychosis (FEP). Neuroinflammation has been proposed as a potential contributor to these deficits.
Ángel Yorca‐Ruiz +8 more
wiley +1 more source

